Literature DB >> 1387749

Dugbe Nairovirus M RNA: nucleotide sequence and coding strategy.

A C Marriott1, A A el-Ghorr, P A Nuttall.   

Abstract

The coding assignments of the medium-sized (M) RNA segment of the Dugbe (DUG) virus (Nairovirus, Bunyaviridae) were investigated. The complete nucleotide sequence of 4888 nucleotides (nt) contained one long open reading frame in the viral complementary RNA, extending from an AUG start codon at nt 48-50 to a stop codon at nt 4701-4703 (numbered from the 5' terminus of vcRNA). Comparison of the terminal sequences with the ends of the DUG S segment revealed sequence identity between the first nine nucleotides of both segments. No sequence homologies were found with the M segments of other members of the Bunyaviridae, or with their polypeptide products. Expression of portions of the DUG M open reading frame in Escherichia coli demonstrated the carboxyl terminal region of the M open reading frame codes for the G1 structural glycoprotein, which is the target for neutralising antibodies. Confirmation of this assignment was obtained by sequencing the amino terminus of the G1 protein. Two nonstructural glycoproteins which share epitopes with G1 were identified in virus-infected cells, one of which (85 kDa) is processed over a period of several hours to produce G1. The G2 coding region was located upstream of the G1 sequence. The region between the carboxyl terminus of G2 and the 5' end of the long open reading frame apparently encodes a nonstructural protein of about 70 kDa, which is a precursor of the G2 protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387749     DOI: 10.1016/0042-6822(92)90898-y

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus.

Authors:  Angela J Sanchez; Martin J Vincent; Stuart T Nichol
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

2.  Crimean-Congo hemorrhagic fever virus genomics and global diversity.

Authors:  Varough M Deyde; Marina L Khristova; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Discovery and evolution of bunyavirids in arctic phantom midges and ancient bunyavirid-like sequences in insect genomes.

Authors:  Matthew J Ballinger; Jeremy A Bruenn; John Hay; Donna Czechowski; Derek J Taylor
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

4.  Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function.

Authors:  Eric Bergeron; César G Albariño; Marina L Khristova; Stuart T Nichol
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 5.  Emerging viruses: the Bunyaviridae.

Authors:  R M Elliott
Journal:  Mol Med       Date:  1997-09       Impact factor: 6.354

6.  Processing and membrane topology of the spike proteins G1 and G2 of Uukuniemi virus.

Authors:  A M Andersson; L Melin; R Persson; E Raschperger; L Wikström; R F Pettersson
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Sequence of rice hoja blanca tenuivirus RNA-2.

Authors:  J R De Miranda; M Muñoz; R Wu; R Hull; A M Espinoza
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

8.  Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreGN that leads to generation of an NSM protein.

Authors:  Louis A Altamura; Andrea Bertolotti-Ciarlet; Jeffrey Teigler; Jason Paragas; Connie S Schmaljohn; Robert W Doms
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

9.  [Vulvovaginal candidiasis in childhood--diagnostic and therapeutic results].

Authors:  P Vasileva; K Bozhkova
Journal:  Akush Ginekol (Sofiia)       Date:  2001

10.  Kupe virus, a new virus in the family bunyaviridae, genus nairovirus, kenya.

Authors:  Mary B Crabtree; Rosemary Sang; Barry R Miller
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.